U.S. Clinical Trial: M.D. Anderson Cancer Center Listed a New Clinical Trial to Study TTI-101 in Patients With Stage II-IV Resectable HPV-negative Squamous Cell Carcinoma of the Head and Neck

Press/Media

Period	5 May 2023

Media coverage

Title	U.S. Clinical Trial: M.D. Anderson Cancer Center Listed a New Clinical Trial to Study TTI-101 in Patients With Stage II-IV Resectable HPV-negative Squamous Cell Carcinoma of the Head and Neck
Media name/outlet	India Pharma News
Country/Territory	India
Date	5/05/23
URL	metabase.moreover.com/noarticleurl?type=psh&lni=6863-6P51-JB5M-W19F-00000-00
Persons	Andrew Sikora